Despite having limitations, using IgM antibodies alone for determining recent infection with chikungunya virus (CHIKV) is common practice due to its rapid turn-around time, easy epidemiological surveillance, extended diagnostic window period, widespread use and familiarity and accessibility in resource-limited setting. The gene discussed is CD40LG; the disease is infection.